Here are four highlights:
1. The discussion will focus on the current state of chronic low back pain treatment.
2. Christopher Gilligan, MD, of Boston-based Brigham and Women’s Hospital, and Timothy Deer, MD, of Winchester, Va.-based The Spine and Nerve Centers of the Virginias, will deliver presentations on the clinical aspect of chronic low back pain.
3. Mainstay Medical will highlight ReActiv8, an implantable neurostimulation system designed to treat chronic low back pain.
4. ReActiv8 is CE marked and is undergoing an investigational device exemption trial in the United States.
More articles on devices:
Zyga Technologies receives patent for SImmetry Decorticator: 5 things to know
Stryker gives $375k surgical equipment donation to Mayfield Education & Research Foundation: 5 highlights
SpineGuard, XinRong Medical Group sign distribution agreement for PediGuard: 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
